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Purpose: Recent evidence supports the role of reduced cerebrospinal fluid (CSF) pressure in the pathogenesis of primary
open-angle glaucoma (POAG). We investigated the association of variants in two candidate genes that are important in
CSF  production,  aquaporin  1  (AQP1)  and  solute  carrier  family  4,  sodium  bicarbonate  transporter,  member  10
(SLC4A10), with POAG in the Caucasian population.
Methods: POAG subjects (n=382) met the criteria of glaucomatous optic neuropathy with consistent visual field loss.
Intraocular pressure was not used as an inclusion criterion. Control subjects (n=363) did not meet any of the inclusion
criteria and had no family history of glaucoma. Eleven tagging single nucleotide polymorphisms (SNPs) for AQP1 and
SLC4A10 were genotyped in the POAG and control subjects, using allelic discrimination assays. Genotype frequencies
were compared between the POAG and control subjects, using logistic regression adjusted for gender.
Results: There was no statistically significant difference in genotype frequencies between POAG and control subjects for
any of the tested SNPs in AQP1 and SLC4A10 (p>0.05).
Conclusions: There was no association between common sequence variants in the AQP1 or SLC4A10 genes and POAG
in the Caucasian population. This is the first study to investigate the association between these two candidate genes and
increased risk for POAG.
Primary open-angle glaucoma (POAG; OMIM 137760)
is the most common form of glaucoma, which is the leading
cause of irreversible blindness worldwide [1,2]. POAG is
characterized by a chronic optic neuropathy and progressive
loss of retinal ganglion cells, leading to specific visual field
defects in the absence of a known secondary cause [3,4].
Several  risk  factors  have  been  associated  with  POAG,
including elevated intraocular pressure (IOP), advanced age,
black race, and family history [5]. To date, four causative
genes for POAG from 11 candidate chromosomal loci have
been  identified,  including  MYOC  (myocilin),  OPTN
(optineurin), WDR36 (WD repeat domain 36), and CYP1B1
(cytochrome P450, family 1, subfamily B, polypeptide 1), but
these four genes together account for less than 10% of POAG
cases [6-10].
Recent  studies  have  provided  strong  support  for  the
theory that reduced cerebrospinal fluid (CSF) pressure may
play a role in the pathogenesis of POAG. In a retrospective
review of patients with a history of lumbar puncture at the
Mayo  Clinic  (Rochester,  Minnesota),  Berdahl  et  al.  [11]
reported that the mean CSF pressure was significantly lower
in  POAG  patients  when  compared  with  nonglaucomatous
control patients. A prospective study conducted by Ren et al.
[12] confirmed that the mean CSF pressure is lower in POAG
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patients and in normal tension glaucoma (NTG) patients when
compared  with  nonglaucomatous  control  patients.  A
decreased CSF pressure can lead to an increased translaminar
pressure  difference,  which  is  defined  as  the  pressure
difference between IOP and CSF pressure [13]. When the
translaminar  pressure  difference  is  abnormally  increased,
axoplasmic flow is disrupted, leading to retinal ganglion cell
death  and  optic  disc  changes  characteristic  of  glaucoma
[14-18]. These findings lend support to the hypothesis that a
decreased CSF pressure resulting in an increased translaminar
pressure difference may contribute to the pathogenesis of
glaucoma.
The candidate gene approach is used to study genes that
are hypothesized to play a role in the etiology of a complex
human disease with genetic contributions. This approach has
been successful in identifying genes, such as complement
factor H in age-related macular degeneration [19]. In this
study we investigated aquaporin 1 (AQP1) and solute carrier
family  4,  sodium  bicarbonate  transporter,  member  10
(SLC4A10) as candidate genes for POAG. AQP1 maps to
chromosomal  location  7p14  and  SLC4A10  maps  to
chromosomal  location  2q23-q24,  neither  of  which  is  at  a
known chromosomal locus for POAG listed by the Human
Genome  Organization  [20-23].  Both  of  these  genes  are
expressed in the choroid plexus and have been shown to be
important  in  CSF  production  [20-29].  Knockout  mouse
models of these genes demonstrate a significant reduction in
CSF production and intracranial pressure [22,28].
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93We hypothesized that AQP1 and SLC4A10 have a role in
the pathogenesis of POAG because of their function in CSF
production  and  their  effect  on  the  translaminar  pressure
difference.  In  this  study,  we  investigated  the  association
between sequence variants of these genes with increased risk
for POAG in the Caucasian population.
METHODS
Subjects:  This  study  was  reviewed  and  approved  by  the
Institutional  Review  Board  of  Duke  University  Medical
Center  (Durham,  NC)  and  adhered  to  the  tenets  of  the
Declaration of Helsinki. Informed consent was obtained from
all study participants. Study subjects were recruited from the
Duke University Eye Center (Durham, NC) for a total of 382
subjects with POAG and 363 control subjects. Subjects with
POAG  were  unrelated  and  met  the  following  inclusion
criteria: 1) age of onset greater than 30 years; 2) glaucomatous
optic  neuropathy  in  both  eyes;  and  3)  visual  field  loss
consistent with optic nerve damage in at least one eye [30].
Glaucomatous optic neuropathy was defined as a cup-to-disc
ratio greater than 0.7 or focal loss of the nerve fiber layer
resulting in a notch, associated with a glaucomatous visual
field  defect.  Visual  fields  were  performed  using  standard
automated perimetry or frequency doubling test [2]. IOP was
not used as an inclusion criterion. The exclusion criteria for
POAG subjects included the diagnosis of a secondary form of
glaucoma or a history of ocular trauma. The control subjects
were examined by the same glaucoma subspecialist (RRA)
who examined the POAG subjects. The control subjects were
unrelated and met the following criteria: 1) no first-degree
relative with glaucoma; 2) IOP less than 21 mmHg in both
eyes without treatment; 3) no evidence of glaucomatous optic
neuropathy in either eye; and 4) normal visual field in both
eyes.
Genomic  DNA  genotyping:  Genomic  DNA  was  extracted
from  peripheral  blood  samples  via  alcohol  and  salt
precipitation  using  Gentra  Systems  PUREGENE  DNA
Purification  Kit  (Qiagen,  Valencia,  CA).  Based  on  the
genotype data from the HapMap Project, HaploView software
version 4.1 (Broad Institute, Boston, MA) was used to select
11  tagging  single  nucleotide  polymorphisms  (SNPs)  for
AQP1 and SLC4A10 in the Caucasian population, using an
r2 threshold of 0.6 and a minor allele frequency threshold of
0.05 [31]. TaqMan allelic discrimination assays were used for
genotyping with Assays-On-Demand and Assays-By-Design
products,  according  to  the  standard  protocols  from  the
manufacturer (Applied Biosystems, Foster City, CA) [32]. For
quality  control  purposes,  two  Centre  d'Etude  du
Polymorphisme Humain standards (CEPH, Paris, France) and
quality control samples were placed within and across 384-
well  plates  (Applied  Biosystems,  Foster  City,  CA),  and
laboratory personnel were blinded to the location of these
samples.  Genotype  submission  to  the  analysis  database
required matching genotypes for all quality control samples
and at least 95% genotyping efficiency.
Statistical  analysis:  Analysis  of  Hardy–Weinberg
equilibrium was performed separately for POAG and control
subjects with Genetic Data Analysis (GDA) software [33].
Pairwise  linkage  disequilibrium  (LD)  between  SNPs  was
calculated  with  the  GOLD  software  [34].  Genotype
frequencies in POAG and control subjects were compared by
logistic  regression  with  adjustment  for  gender  using  SAS
software (SAS Institute Inc., Cary, NC). SNP genotypes were
coded according to a log-additive risk model, which assumes
that the risk from carrying a single copy of the variant (minor)
allele  is  midway  between  that  of  zero  copies  (reference
genotype) and of two copies on the logarithmic scale. Power
calculations  were  performed  using  QUANTO  software
according  to  previously  described  methods,  assuming  a
population prevalence of 10% and a log-additive risk model
[35].
RESULTS
A total of 382 POAG subjects and 363 control subjects were
included in the Caucasian data set. Of the POAG subjects, 15
subjects had NTG, defined as a maximum IOP <22 mmHg.
The mean age of onset of POAG in the experimental subjects
was 57.6±14.2 years, and the mean age of control subjects at
the time of ophthalmologic exam was 64.8±9.3 years. The
experimental group was 49.7% female, and the control group
was 59.8% female.
A total of 11 tagging SNPs were selected to cover the LD
blocks of AQP1 and SLC4A10, using HaploView software
(Figure 1). All of these were in Hardy–Weinberg equilibrium
(p>0.01)  in  the  Caucasian  controls.  We  did  not  observe
statistically significant pair-wise LD (with an r2 cut-off of 0.6)
between the four tagging SNPs of AQP1 or the seven tagging
SNPs  of  SLC4A10.  No  significant  genotype  frequency
differences between cases and controls were detected in either
AQP1 or SLC4A10 (Table 1).
For the three SNPs with lower minor allele frequencies
(ranging  from  7%  to  16%  for  rs765840,  rs1399650,  and
rs1979112), our Caucasian data set had >94% power at a two-
tailed significance level of 5% to detect an odds ratio of 2 or
greater. For all other SNPs, our Caucasian data set had >90%
power at a two-tailed significance level of 5% to detect an
odds ratio of 1.5 or greater.
DISCUSSION
Recent studies have shown that CSF pressure is reduced in
POAG subjects as compared to control subjects, suggesting
that CSF pressure may play a role in the pathogenesis of
POAG [11,12]. Decreased CSF pressure leads to an increase
in the translaminar pressure difference. Elevations of IOP also
increase translaminar pressure differences, which have been
shown to disrupt axoplasmic flow and cause retinal ganglion
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94cell death in a glaucomatous pattern [14-18]. Two genes that
are expressed in the choroid plexus and have been shown to
be  important  in  CSF  production  are  AQP1  and  SLC4A10
[20-29]. These two genes were selected out of many other
genes implicated in CSF production because of their selective
expression in the choroid plexus, their functional significance
in water and ion transport, and their demonstrated role in CSF
production in knockout mouse models [20-29]. However, we
did not detect an association between common tagging SNPs
of AQP1 or SLC4A10 and POAG in this study.
In this study we focused on the potential role of genes
associated with CSF production in glaucoma. It is important
to  note  that  AQP1  is  also  expressed  in  the  trabecular
meshwork  and  Schlemm’s  canal  cells  located  within  the
conventional aqueous outflow tract of the eye [36], while
SLC4A10  is  not  [37].  AQP1  is  believed  to  improve  cell
viability in the setting of mechanical strain, but the degree to
Figure  1.  Schematic  of  aquaporin-1
(AQP1)  and  solute  carrier  family  4,
sodium  bicarbonate  transporter,
member  10  (SLC4A10)  genes.  The
locations  of  the  genotyped  tagging
single  nucleotide  polymorphisms
(SNPs)  identified  using  HaploView
software  in  the  AQP1  and  SLC4A10
genes are shown in relation to the exons
that are depicted as vertical boxes or
lines and the introns that are depicted as
a horizontal line.
TABLE 1. MINOR ALLELE FREQUENCIES OF TAGGING SNPS IN THE AQP1 AND SLC4A10 GENES IN CAUCASIAN POAG AND CONTROL
SUBJECTS
Candidate gene SNP Allele
Controls
(n=363)
POAG
(n=382) p-value*
AQP1 rs1004317 G 0.404 0.399 0.786
  rs17159702 G 0.292 0.265 0.297
  rs765840 A 0.067 0.077 0.468
  rs1049305 C 0.412 0.367 0.078
SLC4A10 rs1399650 C 0.157 0.152 0.739
  rs2892769 C 0.451 0.439 0.639
  rs1551051 T 0.267 0.237 0.146
  rs1979112 G 0.121 0.141 0.221
  rs1227929 T 0.409 0.411 0.901
  rs1913807 T 0.207 0.213 0.574
  rs4500960 A 0.490 0.483 0.726
The asterisk indicates that the p-value is from logistic regression with adjustment for sex, using log-additive coding of SNP
genotypes; SNPs: single nucleotide polymorphisms; POAG: primary open-angle glaucoma; AQP1: aquaporin-1; SLC4A10 :
solute carrier family 4, sodium bicarbonate transporter, member 10.
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95which AQP1 contributes to bulk outflow in the conventional
outflow tract of the eye is uncertain [38-40].
It  is  known  that  AQP1  and  SLC4A10  are  major
contributors  to  CSF  production.  Due  to  the  functional
importance  of  AQP1  and  SLC4A10  in  CSF  production,
sequence variants within these two genes might be expected
to  be  more  prevalent  in  NTG  patients  since  both  a
retrospective and a prospective study showed a trend of NTG
patients  having  lower  CSF  pressure  than  POAG  subjects
[12,41]. Our Caucasian data set is composed primarily of
POAG subjects with high tension glaucoma, and only 15
subjects  had  NTG.  Therefore,  this  study  did  not  have
sufficient power to detect an association between AQP1 or
SLC4A10 and an increased risk of NTG.
Our large sample size provided adequate statistical power
to detect a moderate or strong association between common
sequence variants of these two genes and an increased risk of
POAG in the Caucasian population. However, we cannot rule
out the presence of such an association in populations of
different ancestry. It is also possible that only rare sequence
variants in these genes, which our study was not designed to
detect, have an appreciable effect on CSF production and
pressure.  Additionally,  mutations  identified  in  different
regions of AQP1 have been shown to reduce water and ion
transport function [42-43]. Targeted mutations, such as an
exon deletion in SLC4A10 knockout mice, resulted in an 88%
reduction  in  brain  ventricle  size  from  decreased  CSF
production as compared to wild-type mice [28]. The effect of
knockout models of these genes on the optic nerve has not
been described to date. Further studies would be necessary to
identify  naturally  occurring  mutations  in  AQP1  and
SLC4A10 that lead to decreased CSF pressure.
In conclusion, we did not find an association between
common sequence variants in AQP1 and SLC4A10 and high
tension POAG in our Caucasian data set. Further studies are
needed to determine if variants within these two genes are
associated with NTG only or if rare sequence variants with a
greater effect on CSF pressure may play a role in POAG in
populations of Caucasian or non-Caucasian origin.
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